#tropics2 搜尋結果

2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population - Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) - Prolonged mDOR - No new safety signal 3/6

OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6
OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6
OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6

3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo - Improved mPFS (5.5 mos Vs. 4 mos) with Saci - Immature OS data (trend towards OS) - 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 4/5

OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5
OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5
OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5

2. #Sacituzumab govitecan (Trop-2/TOP1 ADC) is already approved for TNBC and bladder cancer. #TROPiCS2 Ph3, HR+/HER2- aBC after ET/CDK4/6i, & ≥2 L chemo: - Met PFS (HR 0.66) & OS (0.79) endpoint - Pending approval - Benefit across all TROP-2 expressions #SABCSUpdate

OncBrothers's tweet image. 2. #Sacituzumab govitecan (Trop-2/TOP1 ADC) is already approved for TNBC and bladder cancer.

#TROPiCS2 Ph3, HR+/HER2- aBC after ET/CDK4/6i, & ≥2 L chemo:
- Met PFS (HR 0.66) & OS (0.79) endpoint
- Pending approval
- Benefit across all TROP-2 expressions

#SABCSUpdate

@RocketLab nos avisa que el clima mejora para la misión #RocketLikeAHurricane de Tropics Nasa y que podrían lanzar la semana que viene! #Tropics2 #RocketLikeAHurricane 🌀🛰🚀

EspacioVirado's tweet image. @RocketLab nos avisa que el clima mejora para la misión #RocketLikeAHurricane de Tropics Nasa y que podrían lanzar la semana que viene!

#Tropics2 #RocketLikeAHurricane 🌀🛰🚀

Hermoso video del despegue de la misión #TROPICS2 a bordo de un cohete #Electron de @RocketLab.

來自 Peter Beck

#tropics2 are now 1-0 had to put the team on my back


Bron bron lead us to the promise land RT @beef_30: #tropics2 = dream team


9. #TROPICS2 at #ASCO22 for HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo - Ph3, N=543, - Improved mPFS (5.5 mos Vs. 4 mos) with Saci - Immature OS data (trend towards OS) - 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab


Weather Meme of the Day: August 22, 2014 - goo.gl/S3dKaN By: @nickliljawx // #tropics2 #weathermeme


Update: A quick peek into the tropics - goo.gl/l4clqy By: @nqlblq // #hurricanes #tropics2


Update: First tropical wave in many weeks may develop, still no threat - goo.gl/68LMWk By: @nickliljawdam // #hurricanes #tropics2


Rain, drought relief, continues across southern high plains - goo.gl/dIwUsx By: @nickliljawx // #rain #tropics2


Hermoso video del despegue de la misión #TROPICS2 a bordo de un cohete #Electron de @RocketLab.

來自 Peter Beck

@RocketLab nos avisa que el clima mejora para la misión #RocketLikeAHurricane de Tropics Nasa y que podrían lanzar la semana que viene! #Tropics2 #RocketLikeAHurricane 🌀🛰🚀

EspacioVirado's tweet image. @RocketLab nos avisa que el clima mejora para la misión #RocketLikeAHurricane de Tropics Nasa y que podrían lanzar la semana que viene!

#Tropics2 #RocketLikeAHurricane 🌀🛰🚀

2. #Sacituzumab govitecan (Trop-2/TOP1 ADC) is already approved for TNBC and bladder cancer. #TROPiCS2 Ph3, HR+/HER2- aBC after ET/CDK4/6i, & ≥2 L chemo: - Met PFS (HR 0.66) & OS (0.79) endpoint - Pending approval - Benefit across all TROP-2 expressions #SABCSUpdate

OncBrothers's tweet image. 2. #Sacituzumab govitecan (Trop-2/TOP1 ADC) is already approved for TNBC and bladder cancer.

#TROPiCS2 Ph3, HR+/HER2- aBC after ET/CDK4/6i, & ≥2 L chemo:
- Met PFS (HR 0.66) & OS (0.79) endpoint
- Pending approval
- Benefit across all TROP-2 expressions

#SABCSUpdate

2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population - Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) - Prolonged mDOR - No new safety signal 3/6

OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6
OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6
OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6

9. #TROPICS2 at #ASCO22 for HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo - Ph3, N=543, - Improved mPFS (5.5 mos Vs. 4 mos) with Saci - Immature OS data (trend towards OS) - 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab


3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo - Improved mPFS (5.5 mos Vs. 4 mos) with Saci - Immature OS data (trend towards OS) - 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 4/5

OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5
OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5
OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5

Update: A quick peek into the tropics - goo.gl/l4clqy By: @nqlblq // #hurricanes #tropics2


Update: First tropical wave in many weeks may develop, still no threat - goo.gl/68LMWk By: @nickliljawdam // #hurricanes #tropics2


Weather Meme of the Day: August 22, 2014 - goo.gl/S3dKaN By: @nickliljawx // #tropics2 #weathermeme


Rain, drought relief, continues across southern high plains - goo.gl/dIwUsx By: @nickliljawx // #rain #tropics2


Bron bron lead us to the promise land RT @beef_30: #tropics2 = dream team


2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population - Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) - Prolonged mDOR - No new safety signal 3/6

OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6
OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6
OncBrothers's tweet image. 2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
 
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79) 

- Prolonged mDOR

- No new safety signal

3/6

3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo - Improved mPFS (5.5 mos Vs. 4 mos) with Saci - Immature OS data (trend towards OS) - 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 4/5

OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5
OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5
OncBrothers's tweet image. 3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo 

- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature  OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab 

4/5

@RocketLab nos avisa que el clima mejora para la misión #RocketLikeAHurricane de Tropics Nasa y que podrían lanzar la semana que viene! #Tropics2 #RocketLikeAHurricane 🌀🛰🚀

EspacioVirado's tweet image. @RocketLab nos avisa que el clima mejora para la misión #RocketLikeAHurricane de Tropics Nasa y que podrían lanzar la semana que viene!

#Tropics2 #RocketLikeAHurricane 🌀🛰🚀

2. #Sacituzumab govitecan (Trop-2/TOP1 ADC) is already approved for TNBC and bladder cancer. #TROPiCS2 Ph3, HR+/HER2- aBC after ET/CDK4/6i, & ≥2 L chemo: - Met PFS (HR 0.66) & OS (0.79) endpoint - Pending approval - Benefit across all TROP-2 expressions #SABCSUpdate

OncBrothers's tweet image. 2. #Sacituzumab govitecan (Trop-2/TOP1 ADC) is already approved for TNBC and bladder cancer.

#TROPiCS2 Ph3, HR+/HER2- aBC after ET/CDK4/6i, & ≥2 L chemo:
- Met PFS (HR 0.66) & OS (0.79) endpoint
- Pending approval
- Benefit across all TROP-2 expressions

#SABCSUpdate

Loading...

Something went wrong.


Something went wrong.


United States Trends